Biohaven Pharmaceutical Holding Co Ltd.: key financial figures for fiscal year 2021 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:

Revenue (FY2021): $462.5M
Net Income/Loss (FY2021): -$848.4M
Total Assets (FY2021): $1.1B
Total Equity (FY2021): -$743.0M
Cash Flows from Operating Activities (FY2021): -$831.1M

Source: Biohaven Pharmaceutical Holding Co Ltd. 10-K filing (FY2021). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.

Biohaven Pharmaceutical Holding Co Ltd.: key financial figures for fiscal year 2021 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:

Revenue (FY2021): $462.5M
Net Income/Loss (FY2021): -$848.4M
Total Assets (FY2021): $1.1B
Total Equity (FY2021): -$743.0M
Cash Flows from Operating Activities (FY2021): -$831.1M

Source: Biohaven Pharmaceutical Holding Co Ltd. 10-K filing (FY2021). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.